Pre-operative evaluations for DBS in dystonia

Movement Disorders

Volumn 26, Issue SUPPL.1, 2011, Pages S17-S22

  Thobois, Stéphane ^a   Taira, Takaomi ^b   Comella, Cynthia ^c   Moro, Elena ^d   Bressman, Susan ^e   Albanese, Alberto ^f  

^a UNIVERSITÉ LYON 1   (France)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e BETH ISRAEL MEDICAL CENTER   (United States)

^f UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

DBS; Dystonia

Indexed keywords

ARTICLE; BRAIN DEPTH STIMULATION; CERVICAL DYSTONIA; CLINICAL ASSESSMENT; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DYSTONIA; FOCAL DYSTONIA; GENERALIZED DYSTONIA; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; MULTICENTER STUDY (TOPIC); NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEGMENTAL DYSTONIA; SHORT FORM 36; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 79959363639     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23481     Document Type: Article

References (110)

1. Bronte-Stewart H, Valldeoriola F, Merello M, et al. Inclusion and exclusion criteria for DBS in Dystonia. In this Mov Disord Suppl 2010 issue.
2. Albanese A, Asmus F, Bhatia KP et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 2010 May 5. [Epub ahead of print].
3. Benabid AL, Deuschl G, Lang AE, Lyons KE, Rezai AR. Deep Brain Stimulation for Parkinson's Disease. Mov Disord 2006; 21 (Suppl 14): S168-S170.
4. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985; 35: 73-77.
5. Guy E. Abnormal Involuntary Movement Scale. 1976. ECDEU Assessment of Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health. Revised 1976.
6. Chouinard G, Margolese HC. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res. 2005 Jul 15; 76(2-3): 247- 265.
7. Tsui JK, Eisen A, Stoessl AJ, Calne S, Calne DB. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986; 2: 245-247.
8. Consky E, Lang A. Clinical assessment of patients with cervical dystonia. In: Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. p 211-237.
9. Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T. Dystonia Study Group. Rating scales for dystonia: a multicenter assessment. Mov Disord 2003; 18: 303-312.
10. Gharabawi GM, Bossie CA, Lasser RA, Turkoz I, Rodriguez S, Chouinard G. Abnormal involuntary movement scale (AIMS) and extrapyramidal symptom rating scale (ESRS): cross-scale comparison in assessing tardive dyskinesia. Schizophr Res 2005; 77: 119-128.
11. Monbaliu E, Ortibus E, Roelens F, et al. Rating scales for dystonia in cerebral palsy: reliability and validity. Dev Med Child Neurol 2010; 52: 570-575.
12. Scientific Advisory Group of the Medical Outcomes Trust. Assessing health status and quality of life instruments: attributes and review criteria. Qual Life Res 2002; 11: 193-205.
13. Cano SJ, Hobart JC, Fitzpatrick R, Bhatia K, Thompson AJ, Warner TT. Patient-based outcomes of cervical dystonia: a review of rating scales. Mov Disord 2004; 19: 1054-1059.
14. Costa J, Espírito-Santo C, Borges A, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005; (1): CD003633.
15. Gronseth G, French J. Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology 2008; 71: 1639-1643.
16. Kupsch A, Benecke R, Müller J, et al. Deep-Brain Stimulation for Dystonia Study Group. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006; 355: 1978-1990.
17. Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005; 352: 459-467.
18. Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol 2007; 6: 223-229.
19. Kiss ZH, Doig-Beyaert K, Eliasziw M, Tsui J, Haffenden A, Suchowersky O. Functional and Stereotactic Section of the Canadian Neurosurgical Society; Canadian Movement Disorders Group. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 2007; 130: 2879-2886.
20. Damier P, Thobois S, Witjas T, et al. French Stimulation for Tardive Dyskinesia (STARDYS) Study Group. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry 2007; 64: 170-176.
21. Vidailhet M, Yelnik J, Lagrange C, et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol 2009; 8: 709-717.
22. Susatia F, Malaty IA, Foote KD, et al. An evaluation of rating scales utilized for deep brain stimulation for dystonia. J Neurol 2010; 257: 44-58.
23. Eltahawy HA, Saint-Cyr J, Poon YY, Moro E, Lang AE, Lozano AM. Pallidal deep brain stimulation in cervical dystonia: clinical outcome in four cases. Can J Neurol Sci 2004; 31: 328-332.
24. Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 1997; 12: 570-575.
25. Ford B, Louis ED, Greene P, Fahn S. Outcome of selective ramisectomy for botulinum toxin resistant torticollis. J Neurol Neurosurg Psychiatry 1998; 65: 472-478.
26. Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999; 53: 1439-1446.
27. Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999; 53: 1431-1438.
28. Kiss ZH, Doig K, Eliasziw M, Ranawaya R, Suchowersky O. The Canadian multicenter trial of pallidal deep brain stimulation for cervical dystonia: preliminary results in three patients. Neurosurg Focus 2004 Jul 15; 17(1): E5.
29. Comella CL, Jankovic J, Shannon KM, et al. Dystonia Study Group. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 2005; 65: 1423-1429.
30. Truong D, Duane DD, Jankovic J, et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 2005; 20: 783-791.
31. Meyer C. Outcome of selective peripheral denervation for cervical dystonia. Stereotact Funct Neurosurg 2001; 77: 44-47.
32. Bittar RG, Yianni J, Wang S, et al. Deep brain stimulation for generalised dystonia and spasmodic torticollis. J Clin Neurosci 2005; 12: 12-16.
33. Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 1997; 12: 100-112.
34. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990; 53: 633-639.
35. Defazio G, Lepore V, Abbruzzese G, et al. Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: a multicenter study. Mov Disord 1994; 9: 616-621.
36. Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 2009; 24: 407-413.
37. Wissel J, Kabus C, Wenzel R, et al. Botulinum toxin in writer's cramp: objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry 1999; 61: 172-175.
38. Bereznai B, Steude U, Seelos K, Bötzel K. Chronic high-frequency globus pallidus internus stimulation in different types of dystonia: a clinical, video, and MRI report of six patients presenting with segmental, cervical, and generalized dystonia. Mov Disord 2002; 17: 138-144.
39. Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry 2005; 76: 1188-1193.
40. Hälbig TD, Gruber D, Kopp UA, Schneider GH, Trottenberg T, Kupsch A. Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life. J Neurol Neurosurg Psychiatry 2005; 76: 1713-1716.
41. Blahak C, Wöhrle JC, Capelle HH, et al. Health-related quality of life in segmental dystonia is improved by bilateral pallidal stimulation. J Neurol 2008; 255: 178-182.
42. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
43. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245 (Suppl 1): S10-S14.
44. Cano SJ, Warner TT, Linacre JM, et al. Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58). Neurology 2004; 63: 1629-1633.
45. Cano SJ, Hobart JC, Edwards M, et al. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. Neurology 2006; 67: 2230-2232.
46. Castelnau P, Cif L, Valente EM, et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 2005; 57: 738-741.
47. Diamond A, Shahed J, Azher S, Dat-Vuong K, Jankovic J. Globus pallidus deep brain stimulation in dystonia. Mov Disord 2006; 21: 692-695.
48. Krauss JK, Pohle T, Weber S, Ozdoba C, Burgunder JM. Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia. Lancet 1999; 354: 837-838.
49. Krauss JK, Loher TJ, Pohle T, et al. Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy. J Neurol Neurosurg Psychiatry 2002; 72: 249-256.
50. Krauss JK, Loher TJ, Weigel R, Capelle HH, Weber S, Burgunder JM. Chronic stimulation of the globus pallidus internus for treatment of non-dYT1 generalized dystonia and choreoathetosis: 2-year follow up. J Neurosurg 2003; 98: 785-792.
51. Tronnier VM, Fogel W. Pallidal stimulation for generalized dystonia. Report of three cases. J Neurosurg 2000; 92: 453-456.
52. Coubes P, Roubertie A, Vayssiere N, Hemm S, Echenne B. Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet 2000; 355: 2220-2221.
53. Coubes P, Cif L, El Fertit H, et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg 2004; 101: 189-194.
54. Alterman RL, Miravite J, Weisz D, Shils JL, Bressman SB, Tagliati M. Sixty hertz pallidal deep brain stimulation for primary torsion dystonia. Neurology 2007; 69: 681-688.
55. Cersosimo MG, Raina GB, Piedimonte F, Antico J, Graff P, Micheli FE. Pallidal surgery for the treatment of primary generalized dystonia: long-term follow-up. Clin Neurol Neurosurg 2008; 110: 145-150.
56. Goto S, Yamada K. Long term continuous bilateral pallidal stimulation produces stimulation independent relief of cervical dystonia. J Neurol Neurosurg Psychiatry 2004; 75: 1506-1507.
57. Goto S, Yamada K, Shimazu H, et al. Impact of bilateral pallidal stimulation on DYT1-generalized dystonia in Japanese patients. Mov Disord 2006; 21: 1785-1787.
58. Grips E, Blahak C, Capelle HH, et al. Patterns of reoccurrence of segmental dystonia after discontinuation of deep brain stimulation. J Neurol Neurosurg Psychiatry 2007; 78: 318-320.
59. Ostrem JL, Marks WJ, Jr, Volz MM, Heath SL, Starr PA. Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord 2007; 22: 1885-1891.
60. Starr PA, Turner RS, Rau G, et al. Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. J Neurosurg 2006; 104: 488-501.
61. Opherk C, Gruber C, Steude U, Dichgans M, Bötzel K. Successful bilateral pallidal stimulation for Meige syndrome and spasmodic torticollis. Neurology 2006 Feb 28; 66(4): E14.
62. Tisch S, Zrinzo L, Limousin P, et al. Effect of electrode contact location on clinical efficacy of pallidal deep brain stimulation in primary generalised dystonia. J Neurol Neurosurg Psychiatry 2007; 78: 1314-1319.
63. Vercueil L, Pollak P, Fraix V, et al. Deep brain stimulation in the treatment of severe dystonia. J Neurol 2001; 248: 695-700.
64. Yianni J, Bain PG, Gregory RP, et al. Post-operative progress of dystonia patients following globus pallidus internus deep brain stimulation. Eur J Neurol 2003; 10: 239-247.
65. Zorzi G, Marras C, Nardocci N, et al. Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord 2005; 20: 1194-1200.
66. Muta D, Goto S, Nishikawa S, et al. Bilateral pallidal stimulation for idiopathic segmental axial dystonia advanced from Meige syndrome refractory to bilateral thalamotomy. Mov Disord 2001; 16: 774-777.
67. Magariños-Ascone CM, Regidor I, Martínez-Castrillo JC, Gómez-Galán M, Figueiras-Méndez R. Pallidal stimulation relieves myoclonus-dystonia syndrome. J Neurol Neurosurg Psychiatry 2005; 76: 989-991.
68. Capelle HH, Weigel R, Krauss JK. Bilateral pallidal stimulation for blepharospasm-oromandibular dystonia (Meige syndrome). Neurology 2003; 60: 2017-2018.
69. Chuang C, Fahn S, Frucht SJ. The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature. J Neurol Neurosurg Psychiatry 2002; 72: 59-67.
70. Cif L, Valente EM, Hemm S, et al. Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord 2004; 19: 724-727.
71. Cif L, Biolsi B, Gavarini S, et al. Antero-ventral internal pallidum stimulation improves behavioral disorders in Lesch-Nyhan disease. Mov Disord 2007; 22: 2126-2129.
72. Krause M, Fogel W, Kloss M, Rasche D, Volkmann J, Tronnier V. Pallidal stimulation for dystonia. Neurosurgery 2004; 55: 1361-1368.
73. Trottenberg T, Paul G, Meissner W, et al. Pallidal and thalamic neurostimulation in severe tardive dystonia. J Neurol Neurosurg Psychiatry 2001; 70: 557-559.
74. Trottenberg T, Volkmann J, Deuschl G, et al. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology 2005; 64: 344-346.
75. Zhang JG, Zhang K, Wang ZC, Ge M, Ma Y. Deep brain stimulation in the treatment of secondary dystonia. Chin Med J (Engl) 2006a; 119: 2069-2074.
76. Zhang JG, Zhang K, Wang ZC. Deep brain stimulation in the treatment of tardive dystonia. Chin Med J (Engl) 2006b; 119: 789-792.
77. Umemura A, Jaggi JL, Dolinskas CA, Stern MB, Baltuch GH. Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome. Case report. J Neurosurg 2004; 100: 706-709.
78. Franzini A, Marras C, Ferroli P, et al. Long-term high-frequency bilateral pallidal stimulation for neuroleptic-induced tardive dystonia. Report of two cases. J Neurosurg 2005; 102: 721-725.
79. Angelini L, Nardocci N, Estienne M, Conti C, Dones I, Broggi G. Life-threatening dystonia-dyskinesias in a child: successful treatment with bilateral pallidal stimulation. Mov Disord 2000; 15: 1010-1102.
80. Isaias IU, Alterman RL, Tagliati M. Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration. Brain 2008; 131: 1895-1902.
81. Magariños-Ascone CM, Regidor I, Gómez-Galán M, Cabañes-Martínez L, Figueiras-Méndez R. Deep brain stimulation in the globus pallidus to treat dystonia: electrophysiological characteristics and 2 years' follow-up in 10 patients. Neuroscience 2008; 152: 558-571.
82. Moro E, Piboolnurak P, Arenovich T, Hung SW, Poon YY, Lozano AM. Pallidal stimulation in cervical dystonia: clinical implications of acute changes in stimulation parameters. Eur J Neurol 2009; 16: 506-512.
83. Tagliati M, Krack P, Volkmann J, et al. Long-term management (includes adverse events, battery change, imaging, trouble shooting, special considerations). In this Mov Disord Suppl 2010 issue.
84. Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S. Magnetic resonance imaging of dystonic states. Adv Neurol 1988; 50: 265-275.
85. Draganski B, Thun-Hohenstein C, Bogdahn U, Winkler J, May A. "Motor circuit" gray matter changes in idiopathic cervical dystonia. Neurology 2003; 61: 1228-1231.
86. Obermann M, Yaldizli O, De Greiff A, et al. Morphometric changes of sensorimotor structures in focal dystonia. Mov Disord 2007; 22: 1117-1123.
87. Schneider S, Feifel E, Ott D, Schumacher M, Lucking CH, Deuschl G. Prolonged MRI T2 times of the lentiform nucleus in idiopathic spasmodic torticollis. Neurology 1994; 44: 846-850.
88. Delmaire C, Vidailhet M, Elbaz A, et al. Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp. Neurology 2007 69: 376-380.
89. Garraux G, Bauer A, Hanakawa T, Wu T, Kansaku K, Hallett M. Changes in brain anatomy in focal hand dystonia. Ann Neurol 2004; 55: 736-739.
90. Egger K, Mueller J, Schocke M, et al. Voxel based morphometry reveals specific gray matter changes in primary dystonia. Mov Disord 2007; 22: 1538-1542.
91. Draganski B, Schneider SA, Fiorio M, et al. Genotype-phenotype interactions in primary dystonias revealed by differential changes in brain structure. Neuroimage 2009; 47: 1141-1147.
92. Lehéricy S, Grand S, Pollak P, et al. Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology 2001; 57: 1055-1066.
93. Sedel F, Saudubray JM, Roze E, Agid Y, Vidailhet M. Movement disorders and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis 2008; 31: 308-318.
94. McNeill A, Birchall D, Hayflick SJ, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008; 70: 1614-1619.
95. Woimant F, Chaine P, Favrole P, Mikol J, Chappuis P. Wilson disease. Rev Neurol (Paris) 2006; 162: 773-781.
96. Naumann M, Warmuth-Metz M, Hillerer C, Solymosi L, Reiners K. 1H magnetic resonance spectroscopy of the lentiform nucleus in primary focal hand dystonia. Mov Disord 1998; 13: 929-933.
97. Federico F, Lucivero V, Simone IL, et al. Proton MR spectroscopy in idiopathic spasmodic torticollis. Neuroradiology 2001; 43: 532-536.
98. Fabbrini G, Pantano P, Totaro P, et al. Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm. Eur J Neurol 2008; 15: 185-189.
99. Bonilha L, de Vries PM, Vincent DJ, et al. Structural white matter abnormalities in patients with idiopathic dystonia. Mov Disord 2007; 22: 1110-1116.
100. Hallett M. Dystonia: abnormal movements result from loss of inhibition. Adv Neurol 2004; 94: 1-9.
101. Ceballos-Baumann AO, Passingham RE, Warner T, Playford ED, Marsden CD, Brooks DJ. Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia. Ann Neurol 1995; 37: 363-372.
102. Playford ED, Passingham RE, Marsden CD, Brooks DJ. Increased activation of frontal areas during arm movement in idiopathic torsion dystonia. Mov Disord 1998; 13: 309-318.
103. Kumar R, Dagher A, Hutchison WD, Lang AE, Lozano AM. Globus pallidus deep brain stimulation for generalized dystonia: clinical and PET investigation. Neurology 1999; 53: 871-874.
104. Detante O, Vercueil L, Thobois S, et al. Globus pallidus internus stimulation in primary generalized dystonia: a H215O PET study. Brain 2004; 127: 1899-1908.
105. Ibanez V, Sadato N, Karp B, Deiber MP, Hallett M. Deficient activation of the motor cortical network in patients with writer's cramp. Neurology 1999; 53: 96-105.
106. Ceballos-Baumann AO, Passingham RE, Marsden CD, Brooks DJ. Motor reorganization in acquired hemidystonia. Ann Neurol 1995; 37: 746-757.
107. Delmaire C, Krainik A, Tézenas du Montcel S, et al. Disorganized somatotopy in the putamen of patients with focal hand dystonia. Neurology 2005; 64: 1391-1396.
108. Thobois S, Ballanger B, Xie-Brustolin J, et al. for the French Stimulation for Tardive dystonia (STARDYS) Study Group. Globus pallidus stimulation reduces frontal hyperactivity in tardive dystonia. J Cereb Blood Flow Metab 2008; 28: 1127-1138.
109. Silvestri S, Seeman MV, Negrete JC, et al. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl) 2000; 152: 174-180.
110. Blin J, Baron JC, Cambon H, et al. Striatal dopamine D2 receptors in tardive dyskinesia: PET study. J Neurol Neurosurg Psychiatry 1989; 52: 1248-1252.